Pipeline threatens to run dry as pharma concentrate on chronic illness.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to the full article PDF.
USD 39.95
Prices may be subject to local taxes which are calculated during checkout
Additional information
Tufts University
Related links
Rights and permissions
About this article
Cite this article
Clarke, T. Drug companies snub antibiotics. Nature (2003). https://doi.org/10.1038/news030915-6
Published:
DOI: https://doi.org/10.1038/news030915-6
This article is cited by
-
Antibiotic faces uncertain future
Nature (2006)